|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,854 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,079,680 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
787,387 |
|
|
Total
Value |
$65,018,530 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
1
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
-13.1%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
|
2024-05-21 |
9,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
852 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 17 of 35
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-08-12 |
4 |
AS |
$94.75 |
$379,000 |
D/D |
(4,000) |
331,324 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-10-14 |
4 |
AS |
$89.89 |
$359,560 |
D/D |
(4,000) |
324,324 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-08-07 |
4 |
S |
$88.10 |
$352,400 |
D/D |
(4,000) |
428,732 |
0 |
- |
|
NGSX |
Neurogesx Inc |
Director |
|
2009-08-17 |
4 |
S |
$7.21 |
$29,844 |
D/D |
(4,119) |
20,621 |
0 |
- |
|
ITMN |
InterMune Inc |
Director |
|
2012-04-06 |
4 |
A |
$0.00 |
$0 |
D/D |
4,225 |
4,225 |
0 |
- |
|
IMUX |
Immunic Inc |
Director |
|
2014-10-08 |
4 |
B |
$17.50 |
$75,005 |
D/D |
4,286 |
25,119 |
2.39 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2005-09-01 |
4 |
AB |
$8.58 |
$38,588 |
D/D |
4,500 |
4,500 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-05-12 |
4 |
D |
$59.30 |
$270,823 |
D/D |
(4,567) |
185,189 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-03-01 |
4 |
D |
$94.76 |
$465,177 |
D/D |
(4,909) |
328,701 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-05-15 |
4 |
D |
$57.44 |
$283,294 |
D/D |
(4,932) |
180,257 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-05-15 |
4 |
D |
$122.78 |
$605,551 |
D/D |
(4,932) |
235,894 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-05-13 |
4 |
D |
$82.71 |
$407,926 |
D/D |
(4,932) |
385,224 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-05-15 |
4 |
D |
$91.50 |
$451,278 |
D/D |
(4,932) |
233,564 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-04-04 |
4 |
OE |
$6.46 |
$32,300 |
D/D |
5,000 |
21,642 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-05-01 |
4 |
OE |
$6.46 |
$32,300 |
D/D |
5,000 |
11,120 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-05-05 |
4 |
OE |
$6.46 |
$32,300 |
D/D |
5,000 |
26,120 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-05-05 |
4 |
AS |
$36.53 |
$182,729 |
D/D |
(5,000) |
3,567 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-05-12 |
4 |
S |
$39.15 |
$195,791 |
D/D |
(5,000) |
3,567 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-05-12 |
4 |
OE |
$6.46 |
$32,300 |
D/D |
5,000 |
16,567 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-05-15 |
4 |
S |
$39.10 |
$195,546 |
D/D |
(5,000) |
3,567 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-05-15 |
4 |
OE |
$6.46 |
$32,300 |
D/D |
5,000 |
8,567 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-07-07 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
8,567 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2009-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
50,440 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2010-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
99,067 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-05-03 |
4 |
S |
$26.68 |
$134,266 |
D/D |
(5,000) |
89,893 |
0 |
- |
|
852 Records found
|
|
Page 17 of 35 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|